World-first caffeine trial for premature babies
A world-first clinical trial called BabyCCINO is launching in Melbourne to test optimal caffeine doses for very premature babies. Professor Brett Manley from the University of Melbourne leads the study, which will enrol 3,000-4,000 babies across Australia, New Zealand and the United Kingdom. Caffeine has been safely used in neonatal intensive care units for decades to stimulate the breathing centre in premature babies' brains, preventing dangerous pauses in breathing and reducing the need for mechanical ventilation.
See omnystudio.com/listener for privacy information.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.